p63 is the identity switch for uterine/vaginal epithelial cell fate, and disruption of p63 expression by diethylstilbestrol (DES) induces cervical/vaginal adenosis in mice. In this article, we report the expression patterns of p63 isoforms (TA, DN, a, b and g) in mice, focusing on the reproductive tract. We also present the reproductive tract phenotype of female p63 K/K mice. Finally, to better evaluate the potential role of p63 in human development of DES-induced cervical/vaginal adenosis, we describe the ontogeny of p63 in human female fetuses. In adult mice, the DN isoforms of p63 were expressed only in squamous/basal/myoepithelial cells of epithelial tissues, while TA isoforms of p63 were highly expressed in germ cells of the ovary and testis. In fetal mice, the DN and a forms of p63 were expressed in the cloacal and urogenital sinus epithelia. In the female p63 K/K mice, the sinus vagina developed, but p63 K/K sinus vaginal epithelium failed to undergo squamous differentiation confirming an essential role of p63 in squamous epithelial differentiation. Although TAp63 was highly expressed in developing primordial germ cells/oocytes, p63 K/K ovaries and oocytes developed normally. The ontogeny of p63 in female reproductive organs was essentially identical in mouse and human. In the human fetus at the susceptible stage for DES-induced cervical/vaginal adenosis, most cervical/vaginal epithelial cells were columnar and negative for p63. Therefore, inhibition of p63 expression by DES should change the cell fate of human Müllerian duct epithelial cells and cause cervical/vaginal adenosis as previously demonstrated in mouse. q
Introduction
The p63 transcription factor is the product of TP63 gene, which is transcribed into isoforms containing or lacking the N-terminal transactivation domain, TA and DN forms, respectively. While alternative splicing and different translation initiation sites produce two alternative sequences for the TA and DN isoforms in the N-terminal domain, alternative splicing also generates three additional C-terminal sequences corresponding a, b and g forms. Therefore, there are six potential isoforms for p63 (Yang et al., 1998) . Both TA and DN forms have different functional roles in the developing epidermis. In the mouse, the balance between the two isoforms influences proper epidermal differentiation (Koster et al., 2004) . In zebrafish, DN isoforms are essential for epidermal development (Bakkers et al., 2002; Lee and Kimelman, 2002) . In vitro studies have shown that the TA and DN forms have different transcriptional activity (Wu et al., 2003; Yang et al., 1998) . The C-terminal variants (a, b and g) also have different effects on the transcriptional activity of the p63 protein (Ghioni et al., 2002; Serber et al., 2002) . Therefore, it is essential to differentiate p63 isoforms for better understanding of p63 function. Here, we report the expression pattern of p63 isoforms in different tissues to understand the function of p63 isoforms in vivo.
Previously, we identified p63 as the identity switch for uterine/vaginal epithelial cell fate Kurita et al., 2004b) . Epithelial cells in the cranial portion of vagina (Mü llerian vagina) and uterus develop from Müllerian duct. In the adult, p63 is expressed only in Mechanisms of Development 122 (2005) vaginal epithelium. In the developing mouse Müllerian duct, p63 expression precedes squamous differentiation of vaginal epithelium, and targeted disruption of Tp63 gene transforms Müllerian vaginal epithelium into uterine epithelium (Kurita et al., 2004b) . The current report expands on these findings by analysis of the expression patterns of both TA and DN p63 isoforms in the various components of the developing and adult Müllerian duct. To connect expression pattern to function, phenotypes of p63 K/K mice were evaluated in the sinus vagina and ovary. Earlier work in the mouse has demonstrated that diethylstilbestrol (DES) induces cervical/vaginal adenosis by disrupting p63 expression of the cervical/vaginal epithelium Kurita et al., 2004b) . DES, a synthetic non-steroidal estrogen that was prescribed largely during the 1940s-1960s for pregnant women at high risk for miscarriage, was linked in 1971 with the development of clear cell adenocarcinoma of the vagina and cervix in exposed offspring (Herbst et al., 1971) . It is estimated that more than 2 million mothers, daughters and sons were exposed to DES in the United States alone (Giusti et al., 1995) . Cervical/vaginal adenosis, which is defined as the development of columnar epithelium in the ectocervix/ vagina where stratified squamous epithelium normally exists (Robboy et al., 1981) , is commonly found in DES daughters and forms the bed from which the precursor to the cancer arises (Robboy et al., 1984) . The frequencies of adenosis and clear cell adenocarcinoma are directly related to the week in pregnancy when the DES was first given. More than a third of women developed adenosis if DES-treatment started before gestational week 8, while the incidence of adenosis is essentially 0% if started at week 22 or later. These findings show that in some undetermined manner, DES exposure upsets the normal stages of Müllerian duct development.
Perinatal exposure of mice to DES generates a spectrum of reproductive tract lesions similar to those observed in DES daughters (Forsberg, 1976; McLachlan et al., 1980; Plapinger and Bern, 1979) . As in humans, the frequency of cervical/vaginal adenosis in the mouse is directly related to the timing of DES exposure. In the mouse, the fate determination of Müllerian duct epithelial cells to become uterine or cervical/vaginal occurs during the first 7 days of postnatal life (Cunha, 1976; . This is the critical stage for DES-induction of cervical/vaginal adenosis. When female neonatal mice are exposed to DES from birth to day 5, 75% show the presence of vaginal adenosis by the 35th day of life (Newbold and McLachlan, 1982) . In the mouse, DES-exposure during the first 5 days of postnatal development inhibits p63 expression in cervical/vaginal epithelium, and thus cervical/vaginal epithelium is transformed into a simple columnar epithelium expressing uterine epithelial differentiation markers (Kurita et al., 2004b) . The present study examines the ontogeny of p63 in the developing human female reproductive tract to determine whether the scenario of DES-induced cervical/vaginal adenosis in the mouse is applicable to the human.
Results
2.1. DN and TA p63 isoforms are differentially expressed in various tissues of adult male and female mice Distribution of p63 isoforms (TA, DN, a, b and g, Fig. 1 ) in adult mouse organs was examined by RT-PCR and immunohistochemistry. p63 isoforms have differing tissue distributions in female mouse reproductive organs (Fig. 2) . The mRNA for the TA form was detected in all tissues tested, but was highest in the cervix, testis and ovary ( Fig. 2A) . In contrast, the DN forms were detected only in organs containing squamous/basal epithelial cells (cervix, vagina and skin). While mRNA for a and g isoforms were also detected in all organs tested, b isoforms appeared only in the organs containing squamous/basal epithelial cells, similar to the DN splice variants.
Immunohistochemical analysis was used to examine the protein distribution of DN and a p63 isoforms in adult mice (Fig. 2B) . The specificity of the p63 antibody isoforms was confirmed on 293T cell lines transfected with expression vectors containing cDNAs for mouse TAg, DNa or DNg isoforms (not shown). In the female reproductive tract, mouse monoclonal antibodies reactive to all six splice variants of p63 (4A4 and Ab-2, Fig. 1 anti-p63) detected p63 in cervical/vaginal epithelium, oocytes in ovary and in a subset of epithelial cells in the ampulla of oviduct (Fig. 2B, p63 arrows) . In contrast, an antibody specific for DN forms detected proteins only in cervical/vaginal epithelium but not in the uterus, ovary and oviduct (Fig. 2B ). This suggests that p63 proteins in oocyte and oviduct are the TA splice variants. Thus, immunohistochemical and RT-PCR findings were in agreement ( Fig. 2A,B) . Although RT-PCR detected mRNAs for TA, (ovary, oviduct, uterus, cervix and vagina) , testis and skin from 4 weeks old CD-1 mice. All primers were designed to target sequences encoded by two adjacent exons. Genomic DNA from tail was used for negative control. RT-PCR for b-actin (b-act) was performed as control for quality and amount of RNA. (B) Immunohistochemical detection of p63 isoform proteins in female reproductive organs. Three different antibodies were used. p63 antibody recognizes all six isoforms, DN or a forms. DN antibody detects the DN isoform and a antibody detects the a isoform (Fig. 1) . p63 proteins were detected in oocyte in ovary, epithelium in oviduct and vagina. The DN isoforms was detected in vaginal epithelium. The a isoforms were detected in oocyte in ovary and epithelium in vagina. (C) Expression of squamous epithelial marker (K14) and p63 isoforms in various tissues. DN and a isoforms were detected in all K14-positive myoepithelial, squamous and basal epithelial cells. In contrast, germ cells in testis were positive for p63 but not for DN and a forms. a and g splice variants in the uterus, immunohistochemistry could not detect p63 protein in the normal uterus (Fig. 2B ) confirming our previous report (Kurita et al., 2004b) . The isthmus of oviduct was also negative for p63 by immunohistochemistry (not shown). The a forms were detected in cervical/vaginal epithelium and oocytes but not in oviduct (Fig. 2B ) even though the mRNA for a was weakly expressed in oviduct ( Fig. 2A) . Thus, the presence of p63 mRNA does not always correlate with protein expression as judged by IHC.
The DN specific antibody also stained K14-positive basal cells in seminal vesicle and prostate, myoepithelial cells in mammary gland and basal/suprabasal epidermal cells (Fig. 2C, DN) . All of these tissues also showed demonstrable p63 a isoforms (Fig. 2C, a) . In contrast, testicular germ cells were unreactive for DN or a isoforms, but reactive with anti-pan-p63 antibodies (Fig. 2C, p63 ). This confirms that DNp63 isoforms are expressed in squamous/ basal epithelial and myoepithelial cells, while TAp63 forms are expressed in germ cells. Protein for a isoforms was expressed in squamous epithelial tissues and oocytes. These expression patterns suggest functional differences in p63 isoforms in adult male and female urogenital organs and mammary gland. In the testis, immunoreactivity for p63 protein (presumably TAg forms) was undetectable to very low in spermatogonia, totally absent in sperm while very strong in nuclei of spermatocytes and spermatids (Fig. 2C,  p63 ). This expression pattern of p63 protein in testis essentially confirms the previous report by Nakamuta and Kobayashi (2004a) .
Ontogeny of p63 isoforms in mouse Müllerian duct
During epidermal differentiation, mRNAs for TA isoforms of p63 is expressed initially with the start of cell stratification and is followed later by expression of mRNA for DN forms (Koster et al., 2004) . Since DN isoforms seem essential for squamous epithelial differentiation to proceed, we traced the onset of p63 isoforms throughout the developing female reproductive tract. Previously, we showed that p63 is expressed in epithelium in cloaca and urogenital sinus (UGS) at E12 (Kurita et al., 2004a) . At E11.5 (Fig. 3A) , the cloaca was negative for cytokeratin 14 (K14) but its caudal portion exhibited DN and a isoforms. By E14.5, the UGS has developed from cloaca, and the entire epithelium in UGS was positive for DN and a isoforms (Fig. 3B) . By E16.5, the sinus vagina (SVG) was distinct from the UGS and expressed p63 (Fig. 3C ). At E16.5, p63 protein was undetectable in the Müllerian duct and the residual Wolffian duct (Fig. 3C ), but by E18.5 p63-positive cells had gradually increased from caudal to cranial in the columnar epithelium lining the Müllerian duct ( Fig. 3D ), as previously reported (Kurita et al., 2004b) . At E18.5, p63 was detected in small numbers of columnar epithelial cells lining the Müllerian vagina (MVG) (Fig. 3E , arrows), these cells also expressed DN and a (Fig. 3E) forms. Thus, DN and a isoforms were expressed in the Müllerian duct epithelial cells at the earliest stage of p63 expression, before transformation to squamous cells as found lining the adult vagina. In developing mouse skin, expression of TA isoforms precedes that of DN isoforms by at least 2 days; mRNA for TA isoforms was detected at E7.5 while mRNA for DN isoforms appeared only after E9.5 (Koster et al., 2004) . Identical to adult Müllerian vagina, TA, DN, a, b and g isoforms were detected by RT-PCR in the Müllerian vagina of P1 neonatal mice (Fig. 3F) . By P5, the entire Müllerian vagina was lined by p63-positive basal cells as previously reported (Kurita et al., 2004b) , and the basal cells showed immunoreactivity for both DN and a isoforms (not shown). We could not determine if protein for TA isoforms was expressed in developing Müllerian vagina. Nevertheless, it is clear that in the embryonic Müllerian duct, there was no sequential shift in the expression of p63 isoforms from TA to DN as observed in skin development.
Phenotype of p63
K/K sinus vaginal epithelium
While epithelial cells in adult sinus and Müllerian vaginae are indistinguishable, cytomorphology and differentiation markers differ dramatically in epithelial cells of embryonic/neonatal SVG and MVG . Developmental cell linage in Müllerian and sinus vaginal epithelia is also distinctive; Müllerian vaginal epithelium differentiates from p63-negative columnar epithelium, while sinus vaginal epithelium differentiates from p63-positive squamous stratified urogenital sinus epithelium. We have previously reported the phenotype of p63 K/K Müllerian vaginal epithelium, which remains columnar and expresses uterine (endometrial) epithelial differentiation markers (Kurita et al., 2004b) . Therefore, p63 is not just a regulator of squamous differentiation but also the identity switch for epithelial cells in Müllerian vagina/cervix versus uterus. To understand the function of p63 in vaginal epithelial differentiation (identity switch versus squamous differentiation regulator), the phenotypes of p63 K/K SVG was compared to p63
MVG. The rudiments of SVG and MVG from p63 C/C , p63 C/K and p63 K/K embryos were grafted onto kidney of adult female nude mice. p63 haplo-insufficiency was not recognized, and the phenotypes of p63 C/K and p63 C/C SVG were identical (not shown). Epithelial cells in the p63
SVG failed to undergo squamous differentiation, and the columnar epithelial cells were negative for K14 (Fig. 4A,  K14 ). For the keratinization of vaginal epithelium, estrogen signaling through epithelial and stromal ERa is essential (Buchanan et al., 1998; . While ERa was expressed in both epithelial and stromal cells, p63 K/K SVG failed to keratinize and express K10 in response to 17b-estradiol (Fig. 4A, K10) . Therefore, the phenotypes of p63 K/K SVG and MVG were identical in these aspects (Kurita et al., 2004b) . However, the phenotype of p63 K/K SVG and MVG fundamentally differed with regard to progesterone receptor (PR) expression. While epithelial 
cells in p63
K/K MVG grafts expressed high levels of PR in the ovariectomized host (Fig. 4B ,b MVG-E 2 ), PR was undetectable in p63 K/K sinus vaginal epithelial cells in the absence of E 2 (Fig. 4B,d SVG-E 2 ). In p63 K/K sinus vaginal epithelial cells, E 2 induced PR (Fig. 4B ,f SVGCE 2 ) as is the case for normal (p63 C/C ) vaginal epithelium (Fig. 4B ,e SVGCE 2 ) (Kurita et al., 2000) . Thus, PR regulation in p63 K/K MVG corresponds to the adult uterine (endometrial) pattern as reported earlier, whereas PR regulation in p63 K/K SVG corresponds to the vaginal pattern.
Ontogeny of p63 in mouse oocyte
In mouse, p63 protein was detected in primordial germ cell (PGC) as early as E7.5 (Nakamuta and Kobayashi, 2004b) . DN forms were never detected in primordial germ cells (PGCs)/ oocyte between E10.5 and adulthood (not shown). Using antibodies reactive for all six isoforms, p63 was detected by IHC methods in PGCs at E10.5 (Fig. 5A ). p63 expression in PGCs was confirmed with double staining for alkaline phosphatase and p63 (close-up insert in Fig. 5A ). p63 was detected in migrating PGCs (Fig. 5A) , PGCs in the hindgut (Fig. 5B) , in the rudiments of genital ridge at E10.5 (Fig. 5C ) and in the genital ridge at E11.5 when it became prominent (Fig. 5D ). As the genital ridge thickened, PGCs increased in number (Fig. 5E ). On E14.5, p63 was strongly expressed, but the level of expression decreased around E16, and was weak to undetectable at E17.5 (Fig. 5G) . p63 increased at E18.5, with some PGCs reacting strongly for p63 (Fig. 5H , red arrows), and others negative (Fig. 5H, black arrows) . The a forms were initially undetectable in PGCs (not shown), and were first detected in oocytes at E18.5 (Fig. 4I ). p63 expression increased after birth, and was easily detected in most oocytes in primordial follicles at P3 (Fig. 5J ). These oocytes were positive for a forms (Fig. 5K) .
Ovaries of p63
K/K mice Since p63 was expressed in PGCs before the gonads formed, we assessed whether p63 expression was essential for the PGCs and gonads to develop. Ovary and testis were present in p63 K/K embryos at E15-18 (not shown). Ovaries from p63 C/C , p63 C/K and p63 K/K embryos were grafted under the renal capsule of ovariectomized adult female nude mice, and after 1 month were examined histologically. p63 immunoreactivity was detected in the oocytes of ovarian grafts from p63 C/C (Fig. 5L ), p63
(not shown), but not p63 K/K embryos (Fig. 5M ). Nevertheless, p63 K/K ovaries were normal histologically, containing corpus luteum (not shown), primordial, primary and secondary follicles with oocytes (Fig. 5M) . This result suggests that p63 is not essential for development of oocytes, ovaries and follicles. Further detailed studies are required to determine the role of p63 in oocytes. 
Ontogeny of p63 in human female reproductive tract
Previously, we demonstrated that exposure to DES causes adenosis in the developing mouse cervix/vagina by temporarily disrupting p63 expression (Kurita et al., 2004b) . Timing of p63 induction, and thus the cell fate determination in cervical/vaginal epithelial cells is tightly regulated during a critical 5-day time-window (birth to P5), and cervical/vaginal adenosis develops only if DES-exposure occurred during this critical time frame.
To examine the relevance of the mouse model to humans, the ontogeny of p63 expression was studied in human fetal reproductive tracts. p63 was highly expressed in epithelial cells in UGS (Fig. 6A ), but undetectable in the Müllerian duct epithelial cells by post-last-menses (PLM) 11 weeks (not shown). In all four specimens at PLM 12 weeks, a subset of Müllerian duct epithelial cells was positive for p63 in the caudal end of the Müllerian duct (Fig. 6A,C) . The residual Wolffian ducts were unreactive (Fig. 6A-C) . In one PLM 12-week specimen, most of the Müllerian duct was negative throughout for p63 (Fig. 6B) . Other PLM 12-week samples showed some p63 reactive cells in the caudal to middle part of Müllerian duct (Fig. 6C,D) suggesting some variation in the stage of development of the various specimens shown in Fig. 5A-D . In the PLM 12-week specimens containing a higher number of p63-positive cells, p63-positive epithelial cells were organized in a gradient from caudal (high) to cranial (low) in the Müllerian duct (Fig. 6D) as seen in the developing mouse Müllerian duct (Kurita et al., 2004b) . The expression pattern of p63 in human female reproductive tract at PLM 12-13 weeks appears to correspond to the mouse of E16 to P1.
In specimens at PLM 16-18 weeks, the caudal epithelium in the Müllerian duct was already stratified (Fig. 6E) . However, epithelial stratification did not seem to be strictly regulated by p63 since the cranial portion of the stratified epithelium in the human Müllerian duct contained only a few p63 positive epithelial cells (Fig. 6E-G) . Similar to the mouse (Kurita et al., 2004b) , p63-positive epithelial cells did not immediately undergo squamous differentiation in the human Müllerian duct but initially remained columnar (Fig. 6F,G, arrows) . At PLM 18 weeks, K14 was found only in the sinus vagina but not in the Müllerian vagina (not shown). Only a small portion of p63 positive epithelial cells at the caudal Müllerian duct showed squamous morphology (not shown). p63 was never detected in the uterine corpus or Fallopian tubes in any specimen between PLM 12 and 18 weeks (Fig. 6H,I ). In the normal adult, the squamo-columnar junction (SCJ) is located between squamous ectocervical and columnar endocervical epithelia (Fig. 6K, SCJ) . p63 was highly expressed in the vaginal and ectocervical squamous epithelia but not in columnar endocervical (Fig. 6J ) and uterine (endometrial) epithelia (Fig. 6K) . As in the mouse, the boundary of p63 expression changed abruptly at the SCJ. Thus, the p63 expression pattern in human female reproductive tract was essentially identical to that of mice during development and in adulthood.
p63 Expression in human ovary
At PLM 12 weeks, PGCs were observed as cells with large round nuclei (Fig. 7A) . Unlike the mouse, nuclei of PGCs in the ovary of human fetus were devoid of p63, although in some specimens, a subpopulation of PGCs showed weak cytoplasmic reactivity (Fig. 7A, black arrow) . Between PLM 12 and 16 weeks, p63 positive PGCs gradually increased, but most PGCs remained negative (Fig. 7B,C, black arrowheads) .
Discussion
Differential roles of the TA and DN p63 isoforms in skin development have been reported in the mouse. 
Specimens at post-last menstrual period (PLM) 12 weeks (A-D), 16 weeks (E) and 18 weeks (F-I). The junction between Müllerian duct (md) and urogenital sinus (ugs) (A and C). The caudal part of Müllerian (md) and residual Wolffian (wd) ducts (B)
. At PLM 16 weeks, the caudal part of Müllerian duct epithelium was stratified and expressed p63. Arrowhead (E) indicates boundary between stratified and simple columnar epithelium. At PLM 18 weeks, most epithelium in the middle to caudal portion of Müllerian duct was stratified (F and G, arrows indicate p63-positive cells). p63 was undetectable in uterus (H, ut) and oviduct [H (ovd) and I] between PLM 12 and 18. p63 was expressed in the ecto-cervix (J) but not in the endo-cervix (J) or endometrium (K) in adulthood. SCJ, squamocolumnar junction; ecg, endocervical gland. In the embryonic mouse epidermis, expression of mRNA for TA isoforms precedes mRNA for DN isoforms by at least 2 days (Koster et al., 2004) . While expression of TA isoforms appears to correspond to epithelial stratification, expression of DN isoforms appear to be related to terminal differentiation of epidermis. Like epidermis, Müllerian vaginal epithelium also undergoes simple columnar to stratified squamous trans-differentiation during development ). However, sequential TA to DN expression of p63 isoforms was not observed in the developing Müllerian duct. DN forms were already detected in the columnar epithelial cells in the mouse Müllerian vagina at E18.5, the earliest stage of p63 expression. Therefore, the model proposed in epidermis seems not to apply to Müllerian duct.
In p63 K/K mice, normal epidermis and its derivatives (e.g. sweat, mammary and salivary glands) do not form (Mills et al., 1999; Yang et al., 1999) . In the Müllerian vagina of p63 K/K mice, the normally squamous cervical/Müllerian vaginal epithelial cells differentiate into columnar uterine (endometrial) epithelium (Kurita et al., 2004b) . Moreover, p63 K/K UGSs grafted into adult male nude mouse hosts develop prostate lacking basal cells (Kurita et al., 2004a) . In this study, we demonstrated that p63 K/K sinus vaginal epithelium differentiated into columnar epithelial cells. Hence, the essential role of p63 in squamous/basal epithelial differentiation appears to be universal in different tissues. Myoepithelial cells share many characteristics with the basal epithelial cells; they are flat cells residing on the basal lamina of the epithelial tissue and expressing p63 and K14. Therefore, it is likely that differentiation of myoepithelial cells shares the same mechanisms for squamous/basal epithelial differentiation, which is regulated by p63. DN isoforms are the dominant forms in epidermis, mammary gland (Nylander et al., 2002) , prostate (Kurita, unpublished) , sinus and Müllerian vaginae. Moreover, all cells positive for DN isoforms were myoepithelial, basal or squamous epithelial cells (Fig. 8A, epithelial cells) . These observations suggest that DNp63 isoforms are the key regulator of myoepithelial, squamous and basal epithelial differentiation.
Besides myoepithelial/squamous/basal epithelial differentiation, p63 works as the identity switch for uterine versus cervical/vaginal epithelia in the mouse Müllerian duct. In the mouse Müllerian duct, the absence of p63 specifies uterine differentiation, while the presence of p63 specifies cervicovaginal differentiation. Thus, the Müllerian vaginal epithelial cells in p63 K/K mouse express a high level of PR in the absence of E 2 , which is the unique expression pattern of PR for uterine epithelium of rodent. In contrast, p63 is not the identity switch for sinus vagina because p63 K/K sinus vagina maintained its vaginal identity and expressed PR in the normal vaginal pattern. Moreover, while urogenital sinus epithelium (UGE) in p63 K/K embryos fails to express squamous differentiation marker (K14), it expresses other proper differentiation markers for normal (p63 C/C ) UGE (e.g. androgen receptor, uroplakin and involucrin), suggesting that p63 is not essential to determine identity of UGE (Kurita et al., 2004a) . These studies suggest that the role of p63 isoforms in a particular tissue should not be applied automatically to other tissues. Fig. 8 . Expression pattern of p63 isoforms. Most columnar epithelial cells were negative for p63. A subset of oviduct epithelial cells showed immunoreactivity only for anti-p63 antibody (reacts with all six isoforms) but not for anti-DN or a isoforms. In contrast, all squamous/basal/myoepithelial cells expressed DN and a forms. Primordial germ cell (PMG) was positive for p63 but DN and a forms were undetectable. In adult testis, immunoreactivity for p63 protein was highly expressed in nuclei of spermatocyte (SC) and spermatid (ST) but was absent in nucleus of sperm. A small subset of spermatogonia (SG) showed faint immunoreactivity for p63. Since mRNA and proteins for DN forms were not detected, immunoreactivity for anti-p63 (all isoforms) antibody in germ cells and columnar epithelial cells is presumed for TA isoforms [labeled as (TA)]. In the epithelial tissue of female reproductive tract (FRT), p63 was expressed in ampulla of oviduct and vaginal epithelial cells. While the columnar epithelial cells in ampulla were negative for DN and a forms, squamous vaginal epithelial cells expressed DN and a forms.
In contrast to squamous epithelia, oocytes and germ cells in testis express TA isoforms only (Fig. 8A, germ cells) . Therefore, to understand the roles of TAp63 isoforms in vivo, it is critical to determine the phenotype of germ cells in p63 K/K mice. Our histological examination did not detect abnormal phenotypes in p63 K/K ovaries. Moreover, most PGCs in human embryonic ovary did not express at PLM11-18, while mouse PGCs already expressed p63 during the migration. These observations suggest that p63 is not essential for formation and migration of germ cells. Further detailed studies are required to determine the roles of p63 in germ cells and gonadal development. For example, we analyzed p63 C/C and p63 K/K ovarian grafts at a single time point (4 weeks after the grafting). Therefore, long-term effects of loss of p63 in oocytes is not known. Moreover, we do not know if the p63 K/K oocytes are fertile. Although, we could not detect DNp63 protein or mRNA in germ cells, Nakamuta et al., detected mRNA for DNp63 isoform in PGCs and developing testis by RT-PCR (Nakamuta and Kobayashi, 2004a,b) . This is probably due to the difference in the sensitivity of the detection methods, and thus, mRNA for DN isoform may be expressed at a low level in germ cells as well.
Finally, the ontogeny of p63 in the human Müllerian duct was essentially identical to that in the mouse. The developmental stage at PLM 18 weeks appears equivalent to that of P2-P3 mouse. At PLM 18 weeks p63 was expressed in a substantial portion of epithelial cells in the middle to caudal portion of human Müllerian duct destined to form the MVG and exocervix, even though the squamous epithelial phenotype was not yet established. PLM 18 weeks in human is the latest period of susceptibility of embryos to DESinduced cervical/vaginal adenosis, equivalent to P2-3 in the mouse. At earlier stages of human Müllerian duct development, most epithelial cells were negative for p63. If DES inhibits expression of p63 in human fetal cervical/vaginal epithelial cells as in the mouse, squamous differentiation would be inhibited, and thus adenosis would develop in the cervix and vagina. Therefore, the mouse model described above may explain the mechanism of induction of adenosis in DES daughters given the similarity of p63 expression during vaginal/cervical development in mouse and human. The essentially identical ontogeny of p63 in mouse and human reproductive tract suggests a common mechanism that regulates expression of p63 in Müllerian duct epithelial cells in human and mouse. In the mouse, uterine/vaginal epithelial differentiation is induced by respective embryonic mesenchymal cells (Cunha, 1976; . Hence, uterine and vaginal mesenchyme have an established identity during embryonic period. Hox genes are good candidates for the determinants of uterine and vaginal mesenchymal identity. Hox-a and -d genes are expressed in a gradient throughout the female reproductive tracts of both mouse and human fetuses (Izpisua-Belmonte et al., 1990; Ma et al., 1998; Taylor et al., 1997) . Differential expression of hox genes may give uterine and vaginal mesenchyme their identity by determining specific gene expression profiles.
For example, hox-a13 and d13 are expressed only in vagina. Therefore, expression of hox-a13 and -d13 may give vaginal mesenchyme the ability to induce p63 expression in Müllerian vaginal epithelial cells. Indeed, homeotic transformation of uterine to cervical/vaginal epithelium occurs in a mouse strain in which the homeobox sequence of hox-a11 is replaced with homeobox sequence of hox-a13 by gene targeting (A11 13hd/13hd mouse); transcripts of Trp63 gene (p73H) were detected in the uterus of the A11 13hd/13hd mice (Zhao and Potter, 2001 ). It appears to be certain that homeobox genes play a key role in epithelial fate determination in the normal Müllerian duct development in mouse and human. Connection between neonatal DESexposure and hox genes has been suggested (Ma et al., 1998; Taylor et al., 1997) . However, hox-a and -d genes are predominantly expressed in mesenchymal cells while DES inhibits expression of p63 in Müllerian vaginal epithelia cells via epithelial ERa (Kurita et al., 2004b) . DES action on mesenchyme does not inhibit expression of p63 in Müllerian vaginal epithelial cells (Kurita et al., 2004b) . Therefore, mesenchymal genes including hox-a13 and -d13 are not the immediate targets of DES in induction of cervical/vaginal adenosis. The mechanism by which DES disrupts expression of p63 in cervical/vaginal epithelial cells requires further investigation. Since the normal developmental process of cervical/vaginal epithelial cells appears to be the same in mouse and human, the mouse model is useful for understanding the molecular mechanisms of cervical/vaginal adenosis development in DES daughters.
Experimental procedure

RT-PCR
Total RNA was isolated from organs of 4-week-old CD-1 mice with RNA STAT-60 (TEL-TEST, Inc., Friendswood, TX). RNA from three mice were pooled and used for cDNA synthesis. mRNA was also extracted from Müllerian vaginae of eight newborn CD-1 mice using TRI reagent (Sigma) and Oligotex mRNA mini Kit (QIAGEN Science, MD). The cDNA was synthesized from 1 mg total RNA or 200 ng mRNA by using Super Script II (Gibco, Gaithersburg, NY) with random primers (Life Technologies, Carlsbad, CA). All PCR primers were synthesized at the UCSF Biomolecular Resource Center (San Francisco, CA). The integrity of cDNA was confirmed with RT-PCR for b-actin, forward primer 5 0 -AGCCATGTACGTAGCCATCC and reverse primer 5 0 -CTCTCAGCTGTGGTGGTGAA (392 bp product). For detection of the TA splice variants, forward primer 5 0 -ATGAATTTTGAAACTTCACGG TGTG and reverse primer 5 0 -GTCTGAGTCTTGCATGCG GATA were used (305 bp product). For the detection of the DN splice variants, forward primer 5 0 -ATGTTGTACCTGG AAAACAATGCC and reverse primer 5 0 -CAGGCATGGC ACGGATAAC were used (410 bp product).
For detection of the a splice variant, forward primer 5 0 -CACAGGCAGCTGCACGACT and reverse primer 5 0 -TCATTCTCCTTCCTCTTTGATACGC were used (233 bp product). For the b splice variant, forward primer 5 0 -TCCCTCAGCACACGATCGA and reverse primer 5 0 -ACTTGCCAAATCCTGACAATGC (384 bp product) were used. For detection of the g splice variant, forward primer 5 0 -TCCCTCAGCACACGATCGA and reverse primer 5 0 -GACGTCAGACTGTGTCGGAGC (139 bp product) were used. All primer sets were designed to amplify a sequence encoded by two adjacent exons. Thus, genomic DNA did not give products. RT reaction was carried out in 20 ml reaction mixture, and 2 ml (adult tissues) or 0.8 ml (neonatal Müllerian vagina) of the RT-products was used as templates for PCR-reaction. For all primer sets, PCR was performed with the following protocol, denaturing 94 8C 15 s, annealing 62 8C 15 s and extension 72 8C 2 min, 40 cycles with AdvanTaq PCR Kit (Clontech Laboratory, Inc., Palo Alto, CA). For adult tissues, the experiment was repeated three times. A representative image of three experiments was presented as Fig. 1. 
Immunohistochemistry
Methods for immunohistochemical detection have been described . Mouse monoclonal antibodies were used at the following concentrations: anti-ERa 1D5 (1:50, DAKO, Carpentaria, CA), anti-cytokeratin10 (K10, 1:25, DAKO), anti-p63 Ab-2 (1:100, Lab Vision Co., Fremont, CA), anti-p63 4A4 (1:100, Santa Cruz Biotechnology, Santa Cruz, CA) and anti-K14 LE001 (1:5, gift from Dr E.B. Lane, University of Dundee, Dundee, UK). Rabbit anti-PR IgG (1:100) was purchased from DAKO. Rabbit anti-p63a (1:100) and goat anti-DNp63 (1:50) IgGs were purchased from Santa Cruz Biotechnology. To reduce nonspecific binding, anti-DNp63 IgG was pre-absorbed to acetone powder of liver and spleen from p63 K/K embryos. Specificity of antibodies against p63 was confirmed by staining on p63 K/K epidermis, ovary and testis. Specificity for p63 isoforms was confirmed on 293T cell line stably transfected with expression vectors containing cDNA for the TAp63a, DNp63a or DNp63g form. All anti-p63 antibodies did not stain 293T cells transfected with control vector. The anti-pan-p63 antibody stained 293T cell lines expressing TAp63a, DNp63a and DNp63g. The anti-DNp63 antibody stained 293T cells expressing DNp63a and DNp63g, but not cells expressing TAp63a. The anti-DNp63a stained 293T cells expressing DNp63a and TAp63a but not DNp63g.
Animals
Mice were maintained in accordance with the NIH Guide for Care and Use of Laboratory Animals, and the UCSF Laboratory Animals Resource Center committee approved all procedures described here. Balb/c, CD-1, C57B6 and adult female nude mice were purchased from Charles River (Wilmington, MA). p63 K/K embryos were produced by heterozygous intercrosses of p63 Brdm2 mice (Mills et al., 1999) . For grafting experiments, pregnant females were sacrificed at 16-18 days postcoitum, and embryos were harvested. Female reproductive organs from 10 p63 K/K , six p63 C/K and eight p63 C/C embryos were used for our studies. p63 K/K mice were identified visually as limbless, and the body parts of embryos were stored for subsequent genotyping by PCR. Uterine and vaginal rudiments were divided into five parts (ovary, uterus, lower cervixCupper Müllerian vagina, lower Müllerian vagina and sinus vagina) and were grafted under the kidney capsule of intact athymic female mice. Hosts were ovariectomized 4 weeks after grafting. Two weeks after the ovariectomy, hosts were injected with 125 ng E 2 in 100 ml corn oil (tocopherol-stripped, ICN Biomedicals, Inc., Aurora, OH) or 100 ml corn oil alone daily for 3 days before termination. Host nude mice for ovary grafts were ovariectomized at the time of grafting, and the grafts were harvested 4 weeks later. p63 K/K and p63 C/C tissues were grafted on the contralateral kidneys of the same hosts.
Alkaline phosphatase detection
Embryos between E9.5 and E10.5 were fixed in 4% paraformaldehyde PBS for 2 h on ice. The embryos were washed three times in PBS and kept in 70% ethanol at 4 8C overnight. After washing three times with distilled water and two times with staining buffer (100 mM Tris-HCl pH 9.5, 100 mM NaCl, 5 mM MgCl 2 ), embryos were transferred into 10 ml staining buffer containing 80 ml NBT (Nitro-Blue Tetrazolium Chloride, Invitrogen) stock solution (50 mg/ml in 70% dimethyl formamide) and 50 ml BCIP (5-Bromo-4-Chloro-3 0 -Indolyphosphate-p-Toluidine Salt, Invitrogen) stock solution (50 mg/ml in 70% dimethyl formamide) were added to 10 ml staining buffer (100 mM Tris-HCl pH 9.5, 100 mM NaCl, 5 mM MgCl 2 ). After 15 min incubation at room temperature, embryos were washed with PBS three times and fixed with 4% paraformaldehyde for 1 h at room temperature, dehydrated through series of ethanol and embedded into paraffin. The paraffin sections were stained for p63.
Human specimens
Specimens of human fetal reproductive tract from therapeutic pregnancy terminations were collected fresh and were immediately fixed for IHC. Committee on Human Research Approval was gained for the collection of specimens and for the study. Specimens of approximately 11 weeks (nZ1), 12 weeks (nZ4), 13-15 weeks (nZ3), 16 weeks (nZ2) and 18 weeks (nZ2) of post-last menstruation period were analyzed. Samples of normal reproductive tract tissues from adult women in their reproductive years were provided by one of the authors (SJR). The tissues were deemed excess, and otherwise were to be discarded following the pathological examination of the surgical specimens. The excess tissues were anonymized and provided devoid of any 'protected health information (PHI)', and hence were considered as 'exempt' by federal regulation governing human tissues used for research purposes.
